Furthermore, the study revealed a significant association between cell-free DNA (cfDNA) levels and several cancer biomarkers, including estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2), triple-negative breast cancer (TNBC), and triple-positive breast cancer (TPBC). This evidence concerns the gene ESR1 and triple-negative breast carcinoma.